Surmodics to Participate in Upcoming Investor Conferences in March

Rhea-AI Summary

Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and diagnostic technologies, announced its participation in two upcoming investor conferences. The 33rd Oppenheimer Annual Healthcare Conference will be held virtually from March 13-15, 2023, with Surmodics presenting on March 15 at 10:40 a.m. ET. The Sidoti Small-Cap Conference is scheduled for March 22-23, 2023, featuring 1x1 investor meetings but no formal presentation. Investors can access a live webcast of the presentation through the company's website, with replays available for 90 days.

Surmodics focuses on innovative vascular intervention devices and diagnostic technologies, aiming to enhance disease detection and treatment.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences:

The 33rd Oppenheimer Annual Healthcare Conference, which is being held virtually March 13‑15, 2023.

• Management will present on Wednesday, March 15, at 10:40 a.m. ET (9:40 a.m. CT).

The Sidoti Small-Cap Conference, which is being held virtually March 22-23, 2023.

• Management will participate in 1x1 meetings with investors on Wednesday, March 22, and Thursday, March 23. There will be no formal presentation.

To access a live webcast of the presentation, go to “Events & Presentations” under the “Investors” section of the Company’s website at https://surmodics.gcs-web.com/events-and-presentations, and click on the webcast icon under “Upcoming Events.” A replay of the webcast will be archived on the website for the following 90 days.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005120/en/

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When will Surmodics present at the Oppenheimer Annual Healthcare Conference?

Surmodics will present on March 15, 2023, at 10:40 a.m. ET.

What are the dates for the Sidoti Small-Cap Conference involving Surmodics?

The Sidoti Small-Cap Conference will take place from March 22-23, 2023.

Is there a live webcast for Surmodics' upcoming presentations?

Yes, a live webcast will be available on Surmodics' website during the presentations.

Will there be a formal presentation at the Sidoti Small-Cap Conference?

No, Surmodics will not have a formal presentation but will participate in 1x1 meetings.

Where is Surmodics, Inc. headquartered?

Surmodics, Inc. is headquartered in Eden Prairie, Minnesota.